FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103114785> ?p ?o ?g. }

• W2103114785 endingPage "83" @default.
• W2103114785 startingPage "75" @default.
• W2103114785 abstract "Purpose Imatinib mesylate is the front-line targeted therapy for gastrointestinal stromal tumours (GISTs). Patient’s eligibility to adjuvant imatinib after primary tumour resection is currently based on histological and clinical risk assessment. While therapeutic options are clear for the very-low, low and high-risk subpopulations, no standard is actually available for the tumours classified as intermediate. Since we recently validated genomic index (GI), a measure of the level of genomic alterations, as a strong predictor of clinical outcome in GIST, we asked whether it could also represent a novel prognostic factor for the intermediate subgroup. Experimental design 82 intermediate risk patients were selected based on the Armed Forces Institute of Pathology (AFIP) classification for genomic profiling. Results Data revealed that even if studied samples generally harboured a combination of the typical genetic aberrations found in GIST, i.e. 1p, 14q 22q deletions and frequently lost CDKN2A locus on chromosome 9, they profoundly differed from each other on the total number of genomic changes and GI value. Kaplan–Meier analyses of metastatic-free survival unveiled that stratification of the tumours by the GI value at a cutoff of 10 separated the good from the poor prognosis patients, proven that metastatic-risk in GIST intermediate patients is strongly associated with high GI values and genome complexity. Conclusion GI is validated here as a robust marker to predict intermediate-GIST clinical outcome. Applicable in numerous Pathology Laboratories already using array comparative genomic hybridisation (CGH) with formalin-fixed paraffin-embedded (FFPE) samples, this assay presently stands as an efficient tool for the clinical management of intermediate GIST-patients." @default.
• W2103114785 created "2016-06-24" @default.
• W2103114785 creator A5010282104 @default.
• W2103114785 creator A5015197719 @default.
• W2103114785 creator A5024463077 @default.
• W2103114785 creator A5050792030 @default.
• W2103114785 creator A5055867845 @default.
• W2103114785 creator A5055932045 @default.
• W2103114785 creator A5060949051 @default.
• W2103114785 creator A5061469135 @default.
• W2103114785 creator A5071712931 @default.
• W2103114785 creator A5074975947 @default.
• W2103114785 creator A5085957270 @default.
• W2103114785 date "2015-01-01" @default.
• W2103114785 modified "2023-10-16" @default.
• W2103114785 title "Genomic index predicts clinical outcome of intermediate-risk gastrointestinal stromal tumours, providing a new inclusion criterion for imatinib adjuvant therapy" @default.
• W2103114785 cites W126870657 @default.
• W2103114785 cites W143397309 @default.
• W2103114785 cites W1933891757 @default.
• W2103114785 cites W1966631138 @default.
• W2103114785 cites W1969631470 @default.
• W2103114785 cites W1970687736 @default.
• W2103114785 cites W1981491302 @default.
• W2103114785 cites W1987037759 @default.
• W2103114785 cites W1993160129 @default.
• W2103114785 cites W1995930366 @default.
• W2103114785 cites W2008920989 @default.
• W2103114785 cites W2015015957 @default.
• W2103114785 cites W2030379493 @default.
• W2103114785 cites W2038596108 @default.
• W2103114785 cites W2041889823 @default.
• W2103114785 cites W2042529181 @default.
• W2103114785 cites W2044422249 @default.
• W2103114785 cites W2048513224 @default.
• W2103114785 cites W2049772360 @default.
• W2103114785 cites W2059864409 @default.
• W2103114785 cites W2068550669 @default.
• W2103114785 cites W2068926954 @default.
• W2103114785 cites W2086287826 @default.
• W2103114785 cites W2088738032 @default.
• W2103114785 cites W2101214437 @default.
• W2103114785 cites W2108431450 @default.
• W2103114785 cites W2111553417 @default.
• W2103114785 cites W2140626630 @default.
• W2103114785 cites W2150475380 @default.
• W2103114785 cites W2171620774 @default.
• W2103114785 doi "https://doi.org/10.1016/j.ejca.2014.10.014" @default.
• W2103114785 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25466504" @default.
• W2103114785 hasPublicationYear "2015" @default.
• W2103114785 type Work @default.
• W2103114785 sameAs 2103114785 @default.
• W2103114785 citedByCount "25" @default.
• W2103114785 countsByYear W21031147852015 @default.
• W2103114785 countsByYear W21031147852016 @default.
• W2103114785 countsByYear W21031147852018 @default.
• W2103114785 countsByYear W21031147852019 @default.
• W2103114785 countsByYear W21031147852020 @default.
• W2103114785 countsByYear W21031147852021 @default.
• W2103114785 countsByYear W21031147852022 @default.
• W2103114785 countsByYear W21031147852023 @default.
• W2103114785 crossrefType "journal-article" @default.
• W2103114785 hasAuthorship W2103114785A5010282104 @default.
• W2103114785 hasAuthorship W2103114785A5015197719 @default.
• W2103114785 hasAuthorship W2103114785A5024463077 @default.
• W2103114785 hasAuthorship W2103114785A5050792030 @default.
• W2103114785 hasAuthorship W2103114785A5055867845 @default.
• W2103114785 hasAuthorship W2103114785A5055932045 @default.
• W2103114785 hasAuthorship W2103114785A5060949051 @default.
• W2103114785 hasAuthorship W2103114785A5061469135 @default.
• W2103114785 hasAuthorship W2103114785A5071712931 @default.
• W2103114785 hasAuthorship W2103114785A5074975947 @default.
• W2103114785 hasAuthorship W2103114785A5085957270 @default.
• W2103114785 hasConcept C121608353 @default.
• W2103114785 hasConcept C126322002 @default.
• W2103114785 hasConcept C142724271 @default.
• W2103114785 hasConcept C143998085 @default.
• W2103114785 hasConcept C16930146 @default.
• W2103114785 hasConcept C2775922572 @default.
• W2103114785 hasConcept C2777583451 @default.
• W2103114785 hasConcept C2777982462 @default.
• W2103114785 hasConcept C2778729363 @default.
• W2103114785 hasConcept C2780265364 @default.
• W2103114785 hasConcept C3019892230 @default.
• W2103114785 hasConcept C71924100 @default.
• W2103114785 hasConceptScore W2103114785C121608353 @default.
• W2103114785 hasConceptScore W2103114785C126322002 @default.
• W2103114785 hasConceptScore W2103114785C142724271 @default.
• W2103114785 hasConceptScore W2103114785C143998085 @default.
• W2103114785 hasConceptScore W2103114785C16930146 @default.
• W2103114785 hasConceptScore W2103114785C2775922572 @default.
• W2103114785 hasConceptScore W2103114785C2777583451 @default.
• W2103114785 hasConceptScore W2103114785C2777982462 @default.
• W2103114785 hasConceptScore W2103114785C2778729363 @default.
• W2103114785 hasConceptScore W2103114785C2780265364 @default.
• W2103114785 hasConceptScore W2103114785C3019892230 @default.
• W2103114785 hasConceptScore W2103114785C71924100 @default.
• W2103114785 hasFunder F4320337351 @default.
• W2103114785 hasIssue "1" @default.

• next